In accordance with Nasdaq Stockholm AB’s decision, following application from the board of directors of GHP Specialty Care AB (publ), the shares of GHP will be delisted from Nasdaq Stockholm. The last day of trading is on 20 May 2022.
Daniel Öhman, CEO
Tel: +46 (0) 708 55 37 07
Philip Delborn, CFO
Tel: +46 (0) 702 12 52 64
GHP is an internationally active health care provider that operates specialist clinics in a select number of diagnostic areas through the application of a business model that is unique in the health care industry, where leading doctors and medical staff become partners and shareholders. Each clinic specialises in a particular patient group, and this leads to increased efficiency and higher quality. This is the cornerstone of GHP’s business philosophy – “Quality through specialisation”. GHP shares are traded on the Small Cap list of Nasdaq Stockholm under the ticker symbol “GHP”.